読み込み中
22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.
終値時点
$0.7244
−$0.0872 · -10.74%
時間外
$0.7401
+$0.0157 · +2.17%
10月12日 18:30 ET
日中の時刻はETです。市場データは遅延する場合があります。
22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.
日中レンジ
現在 $0.7244
52週レンジ
現在 $0.7244
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
売り
バリュエーション
26
割高
センチメント
40
弱気
リスク
69
高リスク
モメンタム
21
弱含み
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.
日中レンジ
現在 $0.7244
52週レンジ
現在 $0.7244
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 704.9万 USD | 1187.8万 USD | 3220.4万 USD | 4050.1万 USD | 3094.8万 USD |
| 売上原価 | 1018.6万 USD | 1427.8万 USD | 4090万 USD | 3865.4万 USD | 2946.2万 USD |
| 粗利益 | −313.7万 USD | −240万 USD | −869.6万 USD | 184.7万 USD | 148.6万 USD |
| 研究開発 | 68.8万 USD | 113.3万 USD | 264.4万 USD | 357.8万 USD | 391.2万 USD |
| 販売・一般管理 | 759.1万 USD | 1028.7万 USD | 3182.7万 USD | 3223.1万 USD | 2590.8万 USD |
| 営業費用 | 827.9万 USD | 1155万 USD | 3623.5万 USD | 3548.2万 USD | 2989.8万 USD |
| 受取利息 | 8.3万 USD | 7.2万 USD | 21.9万 USD | 31.3万 USD | 32.1万 USD |
| 支払利息 | 145.5万 USD | 209.4万 USD | 936.6万 USD | 5.5万 USD | 5.8万 USD |
| 減価償却費と償却費 | 115.7万 USD | 125.8万 USD | 485.9万 USD | 359.1万 USD | 153.6万 USD |
| 営業利益 | −1141.6万 USD | −1395万 USD | −4493.1万 USD | −3363.5万 USD | −2841.2万 USD |
| 純利益 | −505.4万 USD | −1516.4万 USD | −1.41億 USD | −5980.1万 USD | −3260.9万 USD |
会社概要が更新されました 2026年10月13日.
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
